• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2008年至2012年上海川崎病的流行病学特征

Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012.

作者信息

Chen Jing-Jing, Ma Xiao-Jing, Liu Fang, Yan Wei-Li, Huang Mei-Rong, Huang Min, Huang Guo-Ying

机构信息

From the *Pediatric Heart Center, Children's Hospital of Fudan University; †Pediatric Heart Center, Shanghai Children's Medical Center; and ‡The Speciality of Cardiovascular Disease, Children's Hospital of Shanghai Jiaotong University, Shanghai, China.

出版信息

Pediatr Infect Dis J. 2016 Jan;35(1):7-12. doi: 10.1097/INF.0000000000000914.

DOI:10.1097/INF.0000000000000914
PMID:26372452
Abstract

BACKGROUND

This study was to investigate the epidemiologic trends of Kawasaki disease (KD) and coronary arterial lesions (CALs) in Shanghai from 2008 through 2012.

METHODS

Data were collected by using the network of the KD research group established during the first survey in Shanghai to conduct the third survey, covering the period from 2008 through 2012. Clinical records of 2304 patients with acute KD were retrospectively reviewed. Epidemiologic features of KD were investigated. Univariate and multivariate analyses were performed to identify the risk factors for CAL in patients with KD. The data were compared with the previous 2 surveys covering the periods from 1998 to 2002 and 2003 to 2007, respectively.

RESULTS

The average incidence of KD was 30.3 to 71.9 per 100,000 children aged 0-4 years from 2008 through 2012. Age at onset ranged from 32 days to 11.7 years (median: 2.3 years). The occurrence of KD was more common in summer and spring. A total of 365 (15.9%) cases developed CAL defined as ectasia or aneurysm. Male, age ≤ 1 year, intravenous immunoglobulin (IVIG) unresponsiveness, a smaller administrative dosage and the delayed administration of IVIG (>10 days) were independent risk factors for CAL. The occurrence of CAL seemed less frequent in patients who received IVIG within 5 days after onset of illness.

CONCLUSIONS

The incidence of KD in children has increased over time, and the development of CAL decreased in the past 5 years in Shanghai. Earlier treatment with IVIG (<5 days) was associated with reduced CAL among patients with KD.

摘要

背景

本研究旨在调查2008年至2012年上海川崎病(KD)及冠状动脉病变(CALs)的流行病学趋势。

方法

利用上海首次调查时建立的KD研究组网络收集数据,进行第三次调查,涵盖2008年至2012年期间。回顾性分析2304例急性KD患者的临床记录。调查KD的流行病学特征。进行单因素和多因素分析以确定KD患者发生CAL的危险因素。将数据分别与之前涵盖1998年至2002年和2003年至2007年的两次调查结果进行比较。

结果

2008年至2012年,0至4岁儿童KD的平均发病率为每10万人30.3至71.9例。发病年龄范围为32天至11.7岁(中位数:2.3岁)。KD在春夏季节更为常见。共有365例(15.9%)发生CAL,定义为扩张或动脉瘤。男性、年龄≤1岁、静脉注射免疫球蛋白(IVIG)无反应、较小的给药剂量以及IVIG延迟给药(>10天)是CAL的独立危险因素。发病后5天内接受IVIG治疗的患者中CAL的发生率似乎较低。

结论

上海儿童KD的发病率随时间增加,过去5年CAL的发生率有所下降。KD患者早期使用IVIG(<5天)治疗与CAL发生率降低有关。

相似文献

1
Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012.2008年至2012年上海川崎病的流行病学特征
Pediatr Infect Dis J. 2016 Jan;35(1):7-12. doi: 10.1097/INF.0000000000000914.
2
Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.2013 年至 2017 年上海川崎病的流行病学特征。
J Epidemiol. 2020 Oct 5;30(10):429-435. doi: 10.2188/jea.JE20190065. Epub 2019 Sep 21.
3
Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.冠状动脉病变以及对初始免疫球蛋白耐药的川崎病发病率不断上升。
Int J Cardiol. 2016 Jul 1;214:209-15. doi: 10.1016/j.ijcard.2016.03.017. Epub 2016 Mar 28.
4
[Risk factors for coronary artery lesions in children with Kawasaki disease].[川崎病患儿冠状动脉病变的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2012 Dec;14(12):938-41.
5
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.
6
Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).韩国大田一家医院的川崎病流行病学研究(1987年至2000年)。
Pediatr Infect Dis J. 2004 Jan;23(1):52-5. doi: 10.1097/01.inf.0000105201.92839.ec.
7
[Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].静脉注射免疫球蛋白1g/kg和2g/kg对川崎病的治疗效果:一项比较与随访研究
Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):891-5.
8
[Clinical analysis of 942 cases of Kawasaki disease].942例川崎病临床分析
Zhonghua Er Ke Za Zhi. 2006 May;44(5):324-8.
9
A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.一项关于川崎病静脉注射免疫球蛋白无反应的多中心研究。
Pediatr Cardiol. 2015 Aug;36(6):1166-72. doi: 10.1007/s00246-015-1138-0. Epub 2015 Mar 27.
10
A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?川崎病急性期静脉注射免疫球蛋白治疗的回顾性队列研究:是否越早越好?
Cardiovasc Ther. 2021 Jun 18;2021:6660407. doi: 10.1155/2021/6660407. eCollection 2021.

引用本文的文献

1
Atypical Presentation of Kawasaki Disease With Coronary Artery Aneurysms in a 2.5-Month-Old Infant: A Case Report From Syria.一名2.5个月大婴儿患川崎病伴冠状动脉瘤的非典型表现:来自叙利亚的病例报告
Clin Med Insights Case Rep. 2025 Aug 5;18:11795476251359774. doi: 10.1177/11795476251359774. eCollection 2025.
2
Serum Olink Targeted Proteomics Identifies IL-17A as a Prospective Inflammatory Marker for the Prediction and Diagnosis of Kawasaki Disease.血清Olink靶向蛋白质组学确定白细胞介素-17A作为川崎病预测和诊断的潜在炎症标志物。
J Inflamm Res. 2025 Mar 4;18:3093-3103. doi: 10.2147/JIR.S506154. eCollection 2025.
3
Progression prediction of coronary artery lesions by echocardiography-based ultrasomics analysis in Kawasaki disease.
基于超声组学分析的超声心动图在川崎病冠状动脉病变进展预测中的作用。
Ital J Pediatr. 2024 Sep 18;50(1):185. doi: 10.1186/s13052-024-01739-1.
4
Markers of Endothelial Dysfunction in Kawasaki Disease: An Update.川崎病内皮功能障碍标志物:最新研究进展。
Clin Rev Allergy Immunol. 2024 Feb;66(1):99-111. doi: 10.1007/s12016-024-08985-5. Epub 2024 Mar 11.
5
Development of a prediction model for progression of coronary artery lesions in Kawasaki disease.川崎病冠状动脉病变进展预测模型的开发
Pediatr Res. 2024 Mar;95(4):1041-1050. doi: 10.1038/s41390-023-02931-5. Epub 2023 Dec 1.
6
Very early onset of coronary artery aneurysm in a 3-month infant with Kawasaki disease: a case report and literature review.3 月龄婴儿川崎病并发冠状动脉瘤:病例报告及文献复习
Ital J Pediatr. 2023 Jun 4;49(1):60. doi: 10.1186/s13052-023-01478-9.
7
The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis.静脉注射免疫球蛋白(IVIG)治疗窗及其与川崎病临床结局的相关性:系统评价和荟萃分析。
Ital J Pediatr. 2023 Apr 11;49(1):45. doi: 10.1186/s13052-023-01451-6.
8
Medication analysis and pharmaceutical care for a child with Kawasaki disease: A case report and review of the literature.川崎病患儿的药物分析与药学监护:病例报告并文献复习。
Medicine (Baltimore). 2023 Jan 6;102(1):e32488. doi: 10.1097/MD.0000000000032488.
9
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.川崎病患者血栓治疗中应用组织型纤溶酶原激活物:单中心研究。
Pediatr Rheumatol Online J. 2022 Dec 5;20(1):111. doi: 10.1186/s12969-022-00767-7.
10
Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study.川崎病患者白蛋白水平与冠状动脉病变进展:一项回顾性队列研究。
Front Pediatr. 2022 Sep 14;10:947059. doi: 10.3389/fped.2022.947059. eCollection 2022.